Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
CBT 200 Climbs 1.52%. More details...
Biotech Has a 4% Week. More details...
CBT 200 Drops 23 Points. More details...
Biotech Closes In On 2004-2005 High. More details...
Will Higher Scrutiny of Drugs Result?. More details...
CBT 200 Gains 2.4% in Week. More details...
Oil Companies Dominate Profits But Pharma Has Best...
Investors Should Be Skeptical of Objective Responses....
The Good, the Bad, and the Ugly. More details...
CBT 200 Adds on 31 Points. More details...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
